Introduction: Nanotechnology has been studied for several years for its applications in medicine, particularly silver nanoparticles (AgNPs), which have demonstrated excellent antimicrobial results and have been proposed as an alternative to combat bacterial resistance to antibiotic therapy. However, the development of bacterial resistance to AgNPs has been minimally explored, and bacteria of medical and dental interest have already been reported as resistant, raising concerns about their efficacy. This resistance appears to stems from the production of bacterial appendage proteins, which trigger the aggregation of nanoparticles, rendering them ineffective. Objective: This study aims to evaluate the stability of AgNPs at different concentrations when administered to a standard strain of Klebsiella pneumoniae, a Gram-negative bacterium particularly in that produces bacterial appendage. Methodology: AgNPs were synthesized using the bottom-up chemical method. Silver nitrate was reduced with sodium borohydride to produce a colloidal solution, which was stabilized by cappeing with alpha lipoic acid. An aliquot of 30 mL of the sodium borohydride solution was cooled and stirred for 1 hour at 0 ºC an ultra-thermostatic bath. Subsequently, 10 mL of silver nitrate was added to the solution and, after seven minutes in the dark, a yellow-colored colloidal silver was observed. The silver nanoparticles were characterized using the following techniques: Uv-Vis spectroscopy, dynamic light scattering, infrared spectroscopy and X-ray diffraction. Antimicrobial susceptibility tests, such as minimum inhibitory concentration and minimum bactericidal concentration, were carried out on nanoparticles with and without cappeing at different concentration and performed in triplicate. The minimum inhibitory concentration test followed CLSI (Clinical and Laboratory Standards Institute) guidelines M07A11 and M100S22, while the minimum bactericidal concentration was determined using the microdrop technique on brain-heart-infusion agar. Results: Agglomeration of the uncapped AgNPs was observed at all concentrations tested, with resulted in bacterial growth during both the minimum inhibitory concentration and minimum bactericidal concentration assays. In contrast, the nanoparticles capped with alpha lipoic acid exhibited both inhibitory and bactericidal effect against planktonic cells. In the analysis of variance with Tukey's post-hoc test of the group without cappeing, there was no significance between the control group and the other concentrations studied, however, in the group with cappeing, all groups presented significance ˂ 0.0001. Conclusion: The mechanism of bacterial resistance to AgNPs can be overcome by stabilization with alpha lipoic acid, enabling an inhibitory and bactericidal effect. The capping provides stability in biological systems, where various biomacromolecules can bind to the surface of the nanoparticles and hinder their interaction. Furthermore, the stabilized nanoparticle retain the antimicrobial action of the AgNPs and hold potential for applications in human and animal health, particularly in diagnostics and targeted drug delivery.